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Identification of glomerular immune deposits in cryoglobulinemia
glomerulonephritis. To provide further evidence of the nature of intraglo-
merular immune deposits in essential mixed cryoglobulinemia (EMC),
we used two mouse monoclonal antibodies against cross-reactive
idiotypes present on monoclonal rheumatoid factors (MoRFs) from
patients with type ll-EMC. MoAb Ccl reacted with 9 of 16 circulating
IgMk MoRFs tested, and MOAb LcI with four of the remaining. Using
indirect immunofluorescence and immunoperoxidase techniques, we
could identify the same cross-reactive idiotype of the serum MoRF in
the renal biopsy specimens from II of 13 patients with EMC glomeru-
lonephritis. Kidney specimens from the three patients, whose MoRF
was not recognized by MoAbs Ccl and Lcl, were negative. Two Out of
30 control renal biopsies from patients with other forms of glomerulo-
nephritis were shown to contain idiotype (Ccl and Lcl) positive
material. Both patients had serum polyclonal RF which could account
for this finding. In conclusion, our results provide direct evidence that
serum cryo-M0RF participate in the formation of glomerular immune
deposits and, presumably, in the pathogenesis of renal damage in EMC
glomerulonephritis.
Type II essential mixed cryoglobulinemia (EMC) is a disease
characterized by necrotizing vasculitis with purpura, weakness,
arthralgias, often glomerulonephritis, in the absence of under-
lying disorders [1—3]. Immunochemical analysis of circulating
cryoglobulins shows the presence of at least two immunoglob-
ulins, a monoclonal immunoglobulin, usually 1gM, with rheu-
matoid factor activity, which binds the polyclonal lgG to form
a cold-insoluble immune complex [2].
Renal involvement in patients with this disease is likely due
to the deposition of the serum cryoglobulins in the glomeruli. So
far, the evidence supporting this hypothesis is mainly indirect,
it being based on the following observations: 1) the immuno-
globulin classes of the cryoprecipitates are nearly always rep-
resented within the renal immune deposits [4—8]: 2) at electron
microscopy examination, the cryoprecipitates show a fibrillar
appearance closely resembling that of the subendothelial depos-
its of the glomeruli [5, 9]: 3) in the majority of cases the
glomerular immune deposits display an antiglobulin activity
similar to that of serum cryo-IgM [10].
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Shared idiotype specifities among monoclonal 1gM rheuma-
told factors from patients with EMC have been demonstrated
with the use of polyclonal antisera [11] and have been con-
firmed, more recently, using monoclonal antibodies [12—15].
We have therefore studied renal tissue-bound immunoglob-
ulins using mouse hybridoma antibodies raised against the
idiotypes of rheumatoid factors [13] to investigate whether, in
patients with type II EMC, the 1gM found in glomerular
deposits share the same cross-reactive idiotype of the circulat-
ing cryo-IgM rheumatoid factor.
Methods
Seventeen renal biopsies from 16 patients were studied. The
diagnosis of Type II EMC was based on the typical clinical
features of purpura and arthralgias, and the identification of a
cryoglobulin containing an 1gM rheumatoid factor of one light
chain type (Kappa) and polyclonal IgG. All patients showed
renal involvement manifested by pathologic urinary findings
(proteinuria and/or microhematuria), mild to severe impairment
in renal function, and characteristic histologic changes on renal
biopsy specimens [16—l8]. The main clinical and serological
features of all of these patients at the time of biopsy are
summarized in Table 1. None of the patients had serologic
evidence of hepatitis B infection.
Serum C3 and C4 were measured by radial immunodiffusion
[19], and rheumatoid factor activity by the latex agglutination
test (Latex Reagent RF, Behringwerke, Behring Inst, Italy).
As controls, the renal biopsies from 30 other patients were
examined (Table 2). The diagnosis for these patients was made
from renal biopsy material examined by light microscopy and
direct immunofluorescence, as described [20]. Each of these
biopsies had immunoglobulin (1gM in 18) deposition in the
kidney, hut none of the patients had clinical evidence of EMC.
Preparation of rheumatoid factors
Isolation purification and immunochemical analysis of cryo-
globulins were performed as previously described [19, 21].
Briefly, whole blood, clotted at 37°C, was placed at 4°C for
five days. The precipitate was washed in cold phosphate
buffered saline (PBS) twice and cold distilled water twice. The
washed precipitate was then dissolved in Acetate buffer 0.1 M
pH 3.5 and the immunoglobulins separated by gel chromatog-
raphy on a Sephadex G-200 column (Pharmacia Fine Chemi-
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Table 1. Clinical and serological features of the EMC patients at the time of their renal biopsies
Table 2. Immunoglobulin-positive disease control
Control diseases
studied Number
With 1gM
deposits
lgA-N 11 6
MPGN 7 4
MGN 2 1
APSGN 2 0
HS-GN 1 1
SLE-GN 7 6
Total 30 18
Abbreviations are: IgA-N, IgA nephropathy; MPGN, membranopro-
liferative glomerulonephritis Type I; MG, membranous glomerulo-
nephritis; APSGN, acute poststreptococcal glomerulonephritis;
HS-GN, Henoch-Schönlein purpura glomerulonephritis; SLE-GN,
lupus nephritis.
Table 3. Monoclonal antibodies to monoclonal rheumatoid factors
MoAb Subclass Donor of MoRF
Against cross-reactive idiotypes
Ccl IgG 1 C
Lcl IgG I L
Against restricted idiotypes
Cr1 IgG I C
Lrl lgG I L
cats, Uppsala, Sweden). The eluted proteins were pooled and
dialysed against PBS and their constituents analyzed by double
immunodiffusion and immunoelectrophoresis,
Preparation of mouse hybridoma antibodies (MoAbs) to
monoclonal rheumatoid factor idiotypes
The antibodies used in this study have previously been
described [131 and are listed in Table 3.
Two MoAbs which detect two different common idiotypes on
monoclonal rheumatoid factors were used in this study. They
Table 4. Binding of MoAbs (Ccl, Lcl, Cr! and Lrl) to pu
kappa rheumatoid factors
rifled 1gM
Patient Ccl Lcl Cr! Lrl
1 79 18 0 2
2 98 1 2 1
3 89 11 0 0
4 87 4 0 3
5 65 7 3 2
6 89 9 5 0
7 87 2 4 3
8 41 16 1 2
9 76 0 2 1
10 15 89 0 0
1! 7 86 3 2
12 5 67 1 0
13 1 88 2 1
14 1 9 2 6
15 0 4 0 3
16 0 2 1 0
The results are expressed as % binding of a standard monoclonal anti-
1gM antibody.
were raised against patients C and L who are not part of this
study. It should be pointed out that neither of the anti-idiotype
antibodies reacted with 1gM immunoglobulins from normal
donors, 1gM immunoglobulins from patients with myeloma or
Walderström's macroglobulinemia or a variety of IgG or IgA
immunoglobulins or light chains. As previously described for
the Wa idiotype [1!], the two MoAbs against common idiotypes
also bound to polyclonal rheumatoid factors in ELISA, indicating
that these two cross-reactive idiotypes are shared between
monoclonal rheumatoid factors and many polyclonal rheuma-
toid factors. The reactivity pattern of MoAb Ccl was similar to
that described for the anti-Wa reagent [11]. Unfortunately, it
was not possible to compare the two reagents. Two other
MoAbs which bind selectively to the monoclonal rheumatoid
factor against which they were raised and no to other monoclo-
nat rheumatoid factors (restricted or private anti-idiotypes)
were used as controls.
Patient Age/sex Clinical features
Scr
mg/dl
U prot
g/24 hr
Cryocnt C3 C4 RF
titer%
I 69/M P,A,H 2.0 14.0 52 43 5 1:2560
2 58/M P,A,LU,R 2.7 1.3 36 60 5 1:1280
3 54/F P 0.9 2.0 12 45 6 1:160
4 44/M P,H,S 3.0 14.0 21 63 5 1:160
5 56/F P,A,C 1.6 9.6 32 65 6 1:1280
6 5l/M P,A,H 1.6 4.0 5 60 5 1:160
7 61/F P,A,H 1.8 0.8 20 44 5 1:640
8 62/F P,A,H 3.0 0.8 20 77 12 1:160
9 59/M P,A,H 2.4 2.0 20 82 13 1:320
10 49/M P,H,S 1.7 4.0 4 85 5 1:160
II 51/F H 0.8 0.04 3 92 61 1:320
12 42/F P,A,H 1.0 0.13 10 85 10 1:320
50/F P,A,H,LU 1.2 2.00 7 80 5 1:640
13 63/F P,A,H 1.4 0.5 6 62 33 1:20
14 51/M H 2.8 13.0 21 81 20 1:160
15 531M P,N,H,S 3.0 5.5 4 93 15 1:320
16 63/F P,H 0.9 2 5 67 25 1:160
Abbreviations are: P, purpura; A, arthralgias; H, hepatomegaly; LU, leg ulcers; R, Raynaud's phenomenon; S, splenomegaly; C, cirrhosis; N,
neuropathy; Sr, serum creatinine; U prot, urinary proteins; the normal ranges for serum C3 and C4 are 76 to 120 and 50 to 140% of pooled normal
human serum, respectively.
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Table 5. Light microscopy, immunohistochemistry and idiotype findings on the EMC patients
Patient sRF-CRI Histology
Glomerular immune deposits
IgG IgA 1gM C3 C4 Ccl Lcl Cr1 Lrl
1
2
3
4
5
6
7
8
9
10
ii
12
13
14
15
16
Ccl
Ccl
Ccl
Ccl
Ccl
Ccl
Ccl
Ccl
Ccl
Lcl
Lcl
Lcl
Lcl
Lcl
—
—
—
MPGN
MPGN
MPGN
MPGN
MPGN
MPGN
MPGN
MPGN
MPGN
MPGN
MPGN
FPGN
MPGN
FPGN
MPGN
MPGN
MPGN
±
++
+
+
+
+
++
0
++
++
+
+
++
+
0
+
+
0
0
+
+
+
0
0
0
0
+
+
0
0
+
0
+
+
±
++
++
++
++
++
++
±
++
++
++
+
++
+
+
++
++
±
++
+
+
++
0
++
0
+
++
+
+
+
+
+
+
+
0
0
NI)
0
I-
0
0
NI)
0
±
±
±
+
±
0
±
ND
0
+
+
++
+
+
++
0
+
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
+
++
+
++
+
0
0
0
ND
ND
0
0
0
ND
0
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
0
ND
ND
0
0
0
0
ND
ND
ND
ND
Abbreviations are: sRF-CRI, cross-reactive idiotype identified on serum rheumatoid factor; Ccl, Ccl idiotype-positive rheumatoid factor; Lcl,
Lcl idiotype-positive rheumatoid factor; —, unidentified idiotype; MPGN, membranoproliferative glomerulonephritis; FPGN, focal proliferative
glomerulonephritis; ND, not done; the scoring system for the immunohistochemistry and idiotype is on a semiquantitative zero to + + + scale.
Fig. 1. EMC patient 4. Membranoproliferative glomerulonephritis. Staining with MoAb Ccl shows granular glomerular basement membrane
staining with characteristic lobular outline pattern (immunofluorescence )< 500).
ELISA for detection of idiotypes on monoclonal rheumatoid anti-idiotypic reagents [14]. Alternatively this epitope may
factors represent a conformational epitope localized to light or heavy
chain, but destroyed by SDS-PAGE technique. This prompted
us to develop an alternative method for the detection of
idiotypes on monoclonal rheumatoid factors. An ELISA mod-
ification of the RIA previously described [13] was used. Briefly,
microplate wells (Dynatech Deutschland GmbH, Plochingen,
We failed to detect the Ccl epitope on purified monoclonal
rheumatoid factors by immunoblotting (personal observation),
indicating that both light and heavy chains are necessary for the
expression of the Ccl determinant as described for other
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Fig. 2. EMC patient 3. Membranoproliferative glomerulonephritis. Staining with MoAb Ccl shows granular glomerular basement membrane
staining (immunoperoxidase x 1,250). B. Control patient. SLE glomerulonephritis. Section shows no evidence of staining with MoAB Ccl.
(Hematoxylin x 400).
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FRG) were coated overnight at 4°C with a 10 ig/m1 solution of
the purified monoclonal rheumatoid factor in 100 pJ of PBS. The
wells were washed three times with PBS containing 0.05%
Tween 20 (PBS-Tween) and then were blocked by incubation
with PBS supplemented with 10 mg/mI of bovine serum albumin
(BSA) (Sigma Chemical Company, St. Louis, Missouri, USA)
for two hours at room temperature. After three more washes
100 d of the MoAbs were added, and the plates were incubated
for two hours at 37°C. Plates were washed three times in
PBS-Tween and 100 d of Peroxidase-conjugated goat anti-
mouse IgG antiserum, devoid of reactivity with human immu-
noglobulin (Kirkegaard and Perry Laboratories, Inc., Gaithers-
burg, Maryland, USA), diluted 1/1000 in PBS-Tween with 10%
of normal human serum, were added to the wells. After
incubation for one hour at 37°C, wells were washed four times,
and 100 d of the appropriate substrate (ABTS-Hydrogen Per-
oxide; Kirkegaard and Perry Laboratories, Inc.) were added.
After incubation for 30 minutes at room temperature, the
absorbance of each well at 405 nm was read with a Titertek
Multiskan (Flow Laboratories, Rockville, Maryland, USA).
In order to compare experiments performed at different
times, the results were expressed as a binding ratio. Thus the
binding of the test antibody was compared with the binding of a
standard monoclonal anti-IgM antibody (Becton-Dickinson,
Mountain View, California, USA) [14].
This method of expressing the data also allows for correc-
tions for proteins that bound poorly to the plastic microtiter
wells, but does not take into account the different affinity of the
different antibodies.
Detection of idiotype in renal biopsy material
Diagnostic renal biopsies provided the material for this study.
All renal specimens were processed for light microscopy,
immunofluorescence and electron microscopy by standard tech-
niques [16, 20, 22].
Indirect immunofluorescence and immunoperoxidase tech-
niques. Unfixed frozen kidney sections were incubated for 30
minutes at room temperature with the primary monoclonal
antibody. After washing in PBS, the sections were incubated
for 30 minutes with the second antibody (fluorescein or perox-
idase labelled goat F (ab')2 anti-mouse IgG antiserum; Cappel
Laboratories, Cochranville, Pennsylvania, USA). In the case of
immunoperoxidase technique, the reaction was developed with
diaminobenzidine (DAB; Sigma Chemical Company) and H202
and the slides counterstained with Harris' hematoxylin.
All sections were controlled by simultaneous processing of
sections to which the primary antibody had not been applied. In
no case was positive staining seen. As a further control,
sections were also stained, when there was sufficient renal
tissue available, with two mouse monoclonal antibodies (of the
same immunoglobulin subclass) that have specificity for private
idiotypes on monoclonal rheumatoid factors [13].
Inhibition experiments. In addition, from two biopsies which
were found to be positive when stained with Ccl and Let
antibodies, respectively, sufficient material was available to
carry out blocking studies.
Before staining the same concentration of monoclonal anti-
idiotype antibody was incubated with various amounts of
purified serum 1gM kappa rheumatoid factor from the same
patient or with an 1gM kappa rheumatoid factor from another
Table 6. Inhibition studies of anti-idiotype binding to glome
deposits with serum rheumatoid factor
rular
Patient
Pre-incubation with:
Ccl-RF LcP-RF
Pre-incubation 0.5 0.05 0.005 0.5 0.05
with PBS mg/mi mg/mi mg/mi mg/mi mg/mi
0.005
mg/mi
7
12
+++ 0 0 + +++ +++
+++ +++ +++ ++-i- 0 0
+++
Before staining the monoclonal anti-idiotype antibody was incubated
with various amounts of purified rheumatoid factor from the same
patient or with a rheumatoid factor from another patient bearing a
different cross-reactive idiotype or with PBS. Abbreviations are: Cci -
RF, purified rheumatoid factor which bears the Ccl idiotype; Lcl -RF,
purified rheumatoid faclor which bears the Lcl idiotype.
patient bearing a different cross-reactive idiotype. Then the
usual immunofluorescence procedure was followed. For these
experiments, the biopsies were scored on a zero to +++
semiquantitative scale according to the degree of positive
fluorescence staining. As a further control the monoclonal
anti-idiotype antibody was preincubated with PBS or with
inhibiting concentrations of the monoclonal rheumatoid factor
used to produce the anti-idiotypic reagent.
Results
In 11 of the 13 EMC patients (idiotype-positive group), whose
serum rheumatoid factor was recognised by either Ccl or Lcl
antibody, the same cross-reactive idiotype (present on circulat-
ing cryo-IgM rheumatoid factor) was detected in renal biopsy
tissue (Tables 4, 5). In contrast, in the renal biopsies of three
EMC patients, whose serum rheumatoid factor was not reactive
with any of the MoAbs tested (null group), neither the Ccl or
Lcl idiotypes were detected.
The pattern of idiotype-positive material resembled that of
1gM deposits showing diffuse granular staining along glomeruiar
basement membrane (Figs. 1, 2).
There were no correlations between the light microscopy
findings or immunochemistry and the possession (or pattern) of
the cross-reactive idiotypes. However, the two negative cases
in the idiotype-positive group (patients no. 1 and no. 8) had only
trace amounts of 1gM in their glomeruli (Table 5). Patient no. 12
has had two renal biopsies in all. The Lcl idiotype was detected
in the glomerular basement membrane on each occasion. His-
tologically, her biopsy findings changed from a focal prolifera-
tive glomerulonephritis to a membranoproliferative glomerulo-
nephritis.
In one Ccl idiotype-positive biopsy and in one Lcl idiotype
positive biopsy, preincubation with autologous serum rheuma-
toid factor almost completely blocked the binding of the corre-
sponding antibody (Table 6). Preincubation with another rheu-
matoid factor bearing a different cross-reactive idiotype or PBS
had no effect.
In the renal biopsies of two out of 30 controls, both the Ccl
and Lel idiotypes were found (Fig. 3). These two patients had
chronic membranoproliferative glomerulonephritis, one idio-
pathic and the other in association with chronic hepatitis B
infection. Both had rheumatoid factor in their serum detectable
by latex agglutination or ELISA [23]. Moreover, serum from
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the latter was able to inhibit the binding of monoclonal antibody
Lcl to rheumatoid factor idiotype-positive coated plates.
Discussion
Shared idiotypic determinants on antibodies of similar spec-
ificities from different individuals are found in a number of
diseases other than essential cryoglobulinemia. These include
systemic lupus erythematosus [24, 25], autoimmune thyroiditis
[261 and myasthenia gravis [27]. Cross-reactive idiotypes were
originally defined in cryoglobulinemia by Kunkel and his col-
leagues in 1973 using rabbit polyclonal antisera [II]. Recently
the structural basis for this idiotype has been shown by Chen et
al [28] to be a particular amino acid sequence in the CDR2
region of the variable portion of the kappa chain.
Although the levels of cryoglobulins detected in the serum of
EMC patients may reflect disease activity, their potential con-
tribution to the disease's immunopathology as part of immune
reactants deposited within tissue is of greater importance.
Much interest has focused on the kidney damage in EMC
patients, as renal involvement has a deleterious effect on
prognosis [3, 17, 18]. Antiglobulin activity similar to that of
cryo-IgM has been demonstrated in renal tissue from patients
with the most severe histologic changes [10]. However, in a
substantial proportion of patients, 10 over 27, the glomerular
1gM deposits did not display any antiglobulin activity. These
negative findings, however, might have been due to the satura-
tion of binding sites preventing their reaction with aggregated
IgG or to the low sensitivity of the detection system used [10].
We have therefore studied renal tissue-bound immunoglobulins
in EMC patients by a method that is independent of their
rheumatoid factor binding properties. The technique is based
upon the detection of rheumatoid factor idiotypes using mouse
hybridoma antibodies against common idiotypes on monoclonal
rheumatoid factors [131.
This study has shown that the cross-reacting idiotype present
on circulating cryo-IgM rheumatoid factor is also detectable on
the immunoglobulins found in the renal biopsy from 11 out of 13
(84.6%) patients with EMC. This is in agreement with the
observation that ultrastructural examination of both cryopre-
cipitates and glomerular deposits shows the same fibrillar
appearance [5, 9].
It is noteworthy that the two negative patients had only trace
amounts of 1gM in their glomeruli.
The specificity of the reaction was controlled in many dif-
Fig. 3. Ct in nal pa v/cit i. Me rnhra noprol feint i ye
glonierulonephntis associated with chronic hepatitis B
infection. Staining with 1gM antiserum A) MoAb Let Bl and
MoAb Ccl (Cl show granular basement membrane staining
with (he same pattern hut with dillerent intensity 1+ — + for A.
+ + for B. + For Cl linimunutluorescenec 312).
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ferent ways including simultaneous processing of sections with
irrelevant mouse monoclonal antibodies (one against a different
cross-reactive idiotype from that present on autologous serum
rheumatoid factor and, when possible, another against a re-
stricted idiotype) and by inhibition experiments.
Moreover, in the renal biopsies of the three patients whose
rheumatoid factor was not recognized by any of the MoAbs
tested, neither the Ccl or Lc 1 idiotypes were detected.
The presence of both the Ccl and Lcl idiotypes in two of 30
control renal biopsies is not surprising, since intraglomerular
rheumatoid factor activity has been shown in sporadic cases of
patients with primary or secondary glomerulonephritis other
than EMC [10, 29], and MoAbs against common idiotypes
recognises also polyclonal rheumatoid factors. However, the
presence of both the idiotypes in their kidney specimens
distinguishes these two patients from patients with type II EMC
who presented always either the Ccl or Lcl idiotypes in their
glomeruli.
The etiology and the pathogenesis of cryoglobulin formation
and precipitation, as well as the pathogenetic mechanisms of
tissue damage in EMC still remain unclear [16—19, 21]. Type II
cryoglobulins are probably produced as the consequence of an
immunoproliferative disorder of 1gM producing B-lymphocytes
that favors increased production, by selected clones, of mono-
clonal IgMk with rheumatoid factor activity versus polyclonal
IgG, without signs of lymphoplasmacytic neoplasms [13, 16, 17,
19, 21].
It is still debated whether or not this IgG is always bound to
as yet unidentified antigens, probably viral antigens, to form
immune complexes, so that monoclonal 1gM acts as an anti-
immune complex antibody.
However, the recent detection of monoclonal rheumatoid
factor idiotype-expressing cells in the peripheral blood and
bone marrow of subjects with EMC clearly shows that an
expanded clone of cells is present, despite completely normal
morphology [13]. This has been confirmed by the demonstration
of immunoglobulin gene rearrangements in DNA extracted
from peripheral blood lymphocytes (personal observation).
It is also matter of speculation whether or not the renal
lesions are produced in all cases because of an immunologically
mediated mechanism, with cryoglobulins acting at the glomer-
ular level as trapped immune complexes that bind complement.
Alternatively, it has been postulated that local precipitation can
take place because of less specific physicochemical mecha-
nisms, as a consequence of higher endocapillary cryoglobulin
concentration induced by the filtration process at the glomeru-
lar level [16—18].
Our results do not answer these questions but introduce the
use of MoAbs against cross-reactive idiotypes of monoclonal
rheumatoid factors to study the pathogenesis of tissue damage
in this disease.
In conclusion, our results provide direct evidence that serum
cryo-IgM rheumatoid factor participates in the formation of
glomerular immune deposits and, presumably, in the pathogen-
esis of renal damage in EMC.
Moreover, MoAbs reactive against common idiotypic deter-
minants on rheumatoid factors could be of diagnostic value and
may help to elucidate the pathogenesis of renal involvement in
EMC.
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